Email this page

Mandatory fields are marked with an asterisk [*].

Fill in your email details
1. * Your name:
2. * Your email address:
3. * Recipient name:
4. * Recipient email address:
Note: Smith & Nephew does not collect or make use of the email addresses or names provided here. They are only used to show the recipient who has sent the message.
Change the message if you want to
1. To: <recipient name> <address>
2. From: <sender name> <address>
3. Subject: <sender name> is sending you a link
4. Hi,
  I saw this on the Smith & Nephew site and thought you might be interested.
5. <sender name>

R&D:Stem Cells

Investor centre

Investor centre

Sustainability report

Sustainability report 2007
Learn more about our commitment to Sustainable Development in our Sustainability Report

We do not currently use or have any intention of using embryonic stem cells in our research as we do not see any exclusive patient benefits from their use within our chosen fields of orthopaedic reconstruction and trauma, endoscopy and advanced wound management. Our approach has focused exclusively on the use of adult progenitor cells to accelerate repair of damaged tissue.